(Q44541027)

English

Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

Ibrahim Celalettin Haznedaroglu

6

1 reference

Europe PubMed Central

4 December 2017

author name string

Sule Apras

1

1 reference

Europe PubMed Central

4 December 2017

Ihsan Ertenli

2

1 reference

Europe PubMed Central

4 December 2017

Zeynep Ozbalkan

3

1 reference

Europe PubMed Central

4 December 2017

Sedat Kiraz

4

1 reference

Europe PubMed Central

4 December 2017

M Akif Ozturk

5

1 reference

Europe PubMed Central

4 December 2017

Veli Cobankara

7

1 reference

Europe PubMed Central

4 December 2017

Salih Pay

8

1 reference

Europe PubMed Central

4 December 2017

Meral Calguneri

9

1 reference

Europe PubMed Central

4 December 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

4 December 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

4 December 2017

48

1 reference

Europe PubMed Central

4 December 2017

8

1 reference

Europe PubMed Central

4 December 2017

2256-2261

1 reference

Europe PubMed Central

4 December 2017

Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Antiendothelial cell antibodies: useful markers of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Soluble thrombomodulin concentration is raised in scleroderma associated pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Endothelial activation in patients with chronic venous disease

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Treating systemic sclerosis in 2001.

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Pulmonary involvement in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Role of resident mast cell-derived tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Different patterns of endothelial cell activation in renal and pulmonary vascular disease in scleroderma

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Elevated plasma endothelin levels in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Expression of the adhesion molecules ICAM-1, VCAM-1, and E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state

1 reference

https://api.crossref.org/works/10.1002%2FART.11081

21 January 2018

Identifiers

10.1002/ART.11081

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44541027&oldid=2027222320"